Dr Muy-Teck Teh pursued his Biomedical Science degree (B.Sc. Hons, 1996) and PhD in Physiology (2000) from King’s College London
Following two postdoctoral trainings funded by Wellcome Trust and Cancer Research UK, he is currently a tenured Senior Lecturer (Associate Professor) in Head and Neck Cancer at the Barts & the London School of Medicine & Dentistry, Queen Mary University of London, leading a translational research group investigating cancer biomarker discovery, molecular diagnostics, molecular reprogramming of adult epithelial stem cell renewal, differentiation, and senescence. He aims to translate basic science into clinical applications and towards personalised medicine based on molecular signatures.
Dr Teh has international collaborators from USA, Norway, Switzerland, India, Pakistan, Sri Lanka, Malaysia and China on clinical translation of the world’s first FOXM1-based digital squamous cancer test – “qMIDS” for quantitative cancer diagnosis and prognosis.
